Literature DB >> 6793130

Herpes-zoster myelitis treated successfully with vidarabine.

R N Corston, S Logsdail, R B Godwin-Austen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793130      PMCID: PMC1507018          DOI: 10.1136/bmj.283.6293.698-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

Review 1.  ZOSTER ENCEPHALOMYELITIS.

Authors:  F C ROSE; E M BRETT; J BURSTON
Journal:  Arch Neurol       Date:  1964-08

2.  Herpes zoster encephalitis.

Authors:  E APPELBAUM; S I KREPS; A SUNSHINE
Journal:  Am J Med       Date:  1962-01       Impact factor: 4.965

3.  Herpes zoster myelitis. Evidence for viral invasion of spinal cord.

Authors:  E L Hogan; M R Krigman
Journal:  Arch Neurol       Date:  1973-11

Review 4.  Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.

Authors:  R Whitley; C Alford; F Hess; R Buchanan
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

  4 in total
  2 in total

1.  Meningitis and disseminated cutaneous zoster complicating herpes zoster infection.

Authors:  S J Karp
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

2.  Herpes zoster and its neurological complications.

Authors:  C M Chang; E Woo; Y L Yu; C Y Huang; D Chin
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.